Canada markets open in 5 minutes

REGENXBIO Inc. (RGNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.87+0.04 (+0.24%)
At close: 04:00PM EDT
16.87 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-263,494
-263,494
-280,321
127,840
-111,250
Depreciation & amortization
17,320
17,320
12,909
9,564
8,407
Stock based compensation
40,267
40,267
40,788
38,808
31,949
Change in working capital
-10,887
-10,887
13,977
40,218
14,219
Accounts receivable
3,935
3,935
4,822
14,118
-9,898
Accounts Payable
-2,791
-2,791
18,790
-2,304
3,873
Other working capital
-228,367
-228,367
-238,212
134,700
-80,930
Other non-cash items
-95
-95
368
4,361
-1,229
Net cash provided by operating activites
-218,407
-218,407
-207,488
218,875
-54,061
Cash flows from investing activities
Investments in property, plant and equipment
-9,960
-9,960
-30,724
-84,175
-26,869
Purchases of investments
-86,564
-86,564
-184,875
-498,144
-123,041
Sales/Maturities of investments
287,467
287,467
203,670
175,677
272,669
Net cash used for investing activites
190,943
190,943
-11,929
-406,642
122,759
Cash flows from financing activities
Common stock issued
6,700
6,700
1,742
218,206
1,799
Other financing activites
-43,187
-43,187
-33,386
-27,237
192,792
Net cash used privided by (used for) financing activities
-34,966
-34,966
-28,840
195,250
200,214
Net change in cash
-62,430
-62,430
-248,257
7,483
268,912
Cash at beginning of period
98,982
98,982
347,239
339,756
70,844
Cash at end of period
36,552
36,552
98,982
347,239
339,756
Free Cash Flow
Operating Cash Flow
-218,407
-218,407
-207,488
218,875
-54,061
Capital Expenditure
-9,960
-9,960
-30,724
-84,175
-26,869
Free Cash Flow
-228,367
-228,367
-238,212
134,700
-80,930